Sanofi Consumer Healthcare India Limited
NSE: SANOFICONR · Unclassified
Ask the data
Instant answers about Sanofi Consumer Healthcare India Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| Dec '24 | Dec '25 | |
|---|---|---|
| Revenue | 724.5 | 878.4 |
| EBITDA | 270.6 | 309.0 |
| Operating margin | 37.3% | 35.2% |
| Interest | 3.9 | 2.0 |
| Depreciation | 4.5 | 11.7 |
| Profit before tax | 246.8 | 320.3 |
| Tax | 65.8 | 80.2 |
| Net profit | 181.0 | 240.1 |
| EPS ₹ | 78.59 | 104.27 |
| Operating cash flow | 439.0 | 277.4 |
| Capex | 9.9 | 7.6 |
| Dividend paid | 0.0 | 126.7 |
| Total assets | 431.3 | 547.0 |
| Equity | 273.0 | 384.0 |
Quarterly performance
last 10 quarters · ₹ crore| JUN '24 | SEP '24 | DEC '24 | MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 164.4 | 159.9 | 170.7 | 172.6 | 220.9 | 233.9 | 251.0 | 229.2 | 235.7 | 263.1 |
| Operating profit | 63.6 | 63.1 | 62.1 | 64.0 | 70.2 | 85.0 | 89.8 | 88.8 | 89.3 | 101.7 |
| Operating margin | 38.7% | 39.5% | 36.4% | 37.1% | 31.8% | 36.3% | 35.8% | 38.7% | 37.9% | 38.7% |
| Other income | 0.8 | 4.2 | 5.0 | 5.2 | 5.6 | 3.0 | 4.6 | 5.6 | 6.3 | 4.4 |
| Interest | 0.1 | 3.4 | 0.4 | 0.4 | 0.5 | 0.6 | 0.5 | 0.5 | 0.4 | 0.3 |
| Depreciation | 1.1 | 1.5 | 1.0 | 2.0 | 3.0 | 3.3 | 3.4 | 3.2 | 3.3 | 3.1 |
| Profit before tax | 38.9 | 61.2 | 62.8 | 66.8 | 78.9 | 84.1 | 90.5 | 90.7 | 91.9 | 102.7 |
| Tax | 9.9 | 16.2 | 18.5 | 16.8 | 18.2 | 21.2 | 24.0 | 22.9 | 23.1 | 26.1 |
| Net profit | 29.0 | 45.0 | 44.3 | 50.0 | 60.7 | 62.9 | 66.5 | 67.8 | 68.8 | 76.6 |
| EPS ₹ | 12.58 | 19.54 | 19.25 | 21.69 | 26.36 | 27.31 | 28.87 | 29.44 | 29.87 | 33.26 |
| Revenue YoY | — | — | — | — | 34.4% | 46.3% | 47.0% | 32.8% | 6.7% | 12.5% |
| Profit YoY | — | — | — | — | 109.3% | 39.8% | 50.1% | 35.6% | 13.3% | 21.8% |
Returns & margins
trailing-twelve-month, per quarter| MAR '25 | JUN '25 | SEP '25 | DEC '25 | MAR '26 | JUN '26 | SEP '26 | |
|---|---|---|---|---|---|---|---|
| ROE | 61.6% | 77.8% | 84.8% | 62.5% | 67.2% | 76.5% | 80.4% |
| ROCE | 85.7% | 106.8% | 114.6% | 83.9% | 90.2% | 103.2% | 108.5% |
| Net margin | 25.2% | 27.6% | 27.3% | 27.3% | 27.6% | 28.0% | 28.6% |
| EBITDA margin | 37.9% | 35.8% | 35.2% | 35.2% | 35.7% | 37.2% | 37.8% |
| Debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest coverage | 54.42 | 58.38 | 155.00 | 161.15 | 164.90 | 179.60 | 222.06 |
| Asset turnover | 1.55 | 1.72 | 1.89 | 1.61 | 1.71 | 1.34 | 1.39 |
Balance sheet
equity vs borrowings over time · ₹ crore| JUN '24 | DEC '24 | JUN '25 | DEC '25 | JUN '26 | |
|---|---|---|---|---|---|
| Share capital | 23.0 | 23.0 | 23.0 | 23.0 | 23.0 |
| Other equity / reserves | 161.6 | 250.0 | 234.0 | 361.0 | 324.9 |
| Total equity | 184.6 | 273.0 | 257.0 | 384.0 | 347.9 |
| Borrowings | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Current liabilities | 95.2 | 130.6 | 132.9 | 128.4 | 327.1 |
| Non-current liabilities | 27.4 | 27.7 | 32.1 | 34.6 | 31.4 |
| Total assets | 307.2 | 431.3 | 422.0 | 547.0 | 706.4 |
| Property, plant & equipment | 22.9 | 27.2 | 40.6 | 35.1 | 29.5 |
| Capital work-in-progress | — | 0.7 | 0.0 | 0.0 | 0.0 |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Inventories | 53.7 | 40.9 | 78.0 | 61.9 | 93.7 |
| Receivables | 32.6 | 13.7 | 44.4 | 29.6 | 49.8 |
| Cash & equivalents | 118.7 | 326.9 | 216.4 | 374.8 | 490.2 |
Cash flow
annual · ₹ crore · line = free cash flow| Dec '24 | Dec '25 | |
|---|---|---|
| Cash from operations | 439.0 | 277.4 |
| Cash from investing | 1.9 | -7.6 |
| Cash from financing | -115.6 | -221.9 |
| Capex | 9.9 | 7.6 |
| Free cash flow | 429.1 | 269.8 |
| Dividends paid | 0.0 | 126.7 |
Where the assets sit
Jun '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Sanofi Consumer Healthcare India Limited | 7,866 | 3,420.20 | 28.1 | 22.61 | 80.4% |
StoxGud checklist: Neutral setup · 5/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Sanofi Consumer Healthcare India Limited?
Sanofi Consumer Healthcare India Limited (SANOFICONR) closed at ₹3,420.20 on NSE on 06 Nov 2026.
What is the market cap of Sanofi Consumer Healthcare India Limited?
₹7,866 crore at the latest close.
What is the P/E ratio of Sanofi Consumer Healthcare India Limited?
28.1, on trailing-twelve-month earnings from its filings.
How fast is Sanofi Consumer Healthcare India Limited growing?
Sanofi Consumer Healthcare India Limited: Latest-quarter revenue is up 12.5% year on year, profit up 21.8%.
How profitable is Sanofi Consumer Healthcare India Limited?
On a trailing-twelve-month basis return on equity is 80.4%, return on capital employed 108.5%, operating margin 37.8%, net margin 28.6%.
How much debt does Sanofi Consumer Healthcare India Limited have?
Sanofi Consumer Healthcare India Limited is debt-free: debt to equity is 0.00 with borrowings of ₹0 cr against cash of ₹490 cr (balance sheet of 2026-06-30). Operating profit covers interest 222.1 times.
Financials parsed from Sanofi Consumer Healthcare India Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Quarterly from JUN '24, annual from Dec '24, balance sheet from Jun '24. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.